Alena Buyx

Alena Buyx

Auto-generated profile, based on publicly available information

Alena Buyx

Institute of History and Ethics in Medicine, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AFAmelia Fiske
Amelia Fiske
PHPeter Henningsen
Peter Henningsen
ABAlena Buyx
Alena Buyx
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Work in embodied artificial intelligence (AI) has increasing clinical relevance for therapeutic applications in mental health services. With innovations ranging from ‘virtual psychotherapists’ to social robots in dementia care and autism disorder, to robots for sexual disorders, artificially intelligent virtual and robotic agents are increasingly taking on higher-level, therapeutic interventions that used to be offered exclusively by highly trained, skilled health professionals. Embodied AI applications in mental health care carry hopes of improving quality of care and controlling expenditure, as well as reaching underserved populations in need of mental health services, and improving life opportunities for vulnerable groups. However, there is a persistent gap between current, rapid developments in AI mental health, and the successful adoption of these tools into clinical environments by health professionals and patients. In addition, interventions are often designed without any explicit ethical considerations. At present, the quality of research on embodied AI in psychiatry, psychology, and psychotherapy is varied, and there is a marked need for more robust studies, including RCTs on the benefits and potential harms of current and future applications. In light of the demonstrated potential, we provide an analysis of ethical and social implications of currently emerging embodied AI applications in mental health. We argue that embodied AI is a promising approach across the field of mental health, however, further work is needed to address the broader ethical and societal concerns of these technologies in order to negotiate best research and medical practices in innovative mental healthcare. We close by indicating areas of future research and developing recommendations for high-priority areas in need of concrete ethical guidance.

8 February 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
BZBettina Zimmermann
Bettina Zimmermann
AFAmelia Fiske
Amelia Fiske
BPBarbara Prainsack
Barbara Prainsack
NHNora Hangel
Nora Hangel
SMStuart McLennan
Stuart McLennan
ABAlena Buyx
Alena Buyx
Background: The main German-speaking countries (Germany, Austria, and Switzerland) have implemented digital contact tracing apps to assist the authorities with COVID-19 containment strategies. Low user rates for these apps can affect contact tracing and, thus, its usefulness in controlling the spread of the novel coronavirus. Objective: This study aimed to assess the early perceptions of people living in the German-speaking countries and compare them with the frames portrayed in the newspapers during the first wave of the COVID-19 pandemic. Methods: We conducted qualitative interviews with 159 participants of the SolPan project. Of those, 110 participants discussed contact tracing apps and were included in this study. We analyzed articles regarding contact tracing apps from 12 newspapers in the German-speaking countries. Results: Study participants perceived and newspaper coverage in all German-speaking countries framed contact tracing apps as governmental surveillance tools and embedded them in a broader context of technological surveillance. Participants identified trust in authorities, respect of individual privacy, voluntariness, and temporary use of contact tracing apps as prerequisites for democratic compatibility. Newspapers commonly referenced the use of such apps in Asian countries, emphasizing the differences in privacy regulation among these countries. Conclusions: The uptake of digital contact tracing apps in German-speaking countries may be undermined due to privacy risks that are not compensated by potential benefits and are rooted in a deeper skepticism towards digital tools. When authorities plan to implement new digital tools and practices in the future, they should be very transparent and proactive in communicating their objectives and the role of the technology—and how it differs from other, possibly similar, tools. It is also important to publicly address ethical, legal, and social issues related to such technologies prior to their launch.

16 March 2022 in The American Journal of Bioethics
Verified
Journal Article
Open access
LMLukas J. Meier
Lukas J. Meier
AHAlice Hein
Alice Hein
KDKlaus Diepold
Klaus Diepold
ABAlena Buyx
Alena Buyx
Machine intelligence already helps medical staff with a number of tasks. Ethical decision-making, however, has not been handed over to computers. In this proof-of-concept study, we show how an algorithm based on Beauchamp and Childress’ prima-facie principles could be employed to advise on a range of moral dilemma situations that occur in medical institutions. We explain why we chose fuzzy cognitive maps to set up the advisory system and how we utilized machine learning to train it. We report on the difficult task of operationalizing the principles of beneficence, non-maleficence and patient autonomy, and describe how we selected suitable input parameters that we extracted from a training dataset of clinical cases. The first performance results are promising, but an algorithmic approach to ethics also comes with several weaknesses and limitations. Should one really entrust the sensitive domain of clinical ethics to machine intelligence?

12 July 2019 in Journal of Medical Ethics
Verified
Journal Article
Open access
PDF file
AFAmelia Fiske
Amelia Fiske
BPBarbara Prainsack
Barbara Prainsack
ABAlena Buyx
Alena Buyx
In its expansion to genomic, epidemiological and biomedical research, citizen science has been promoted as contributing to the democratisation of medical research and healthcare. At the same time, it has been criticised for reinforcing patterns of exclusion in health and biomedicine, and sometimes even creating new ones. Although citizen science has the potential to make biomedical research more inclusive, the benefits of current citizen science initiatives are not equally accessible for all people—in particular those who are resource-poor, located outside of traditional networks of healthcare services, or members of minorities and marginalised groups. In view of growing public investments in participatory research endeavours, we argue that it should be considered more explicitly if, and how, citizen science could help make research more inclusive, contribute to the public good, and possibly even lead to better and more equitable healthcare. Reflecting on emerging ethical concerns for scientific conduct and best medical practice, we propose a set of relevant considerations for researchers, practitioners, bioethicists, funders and participants who seek to advance ethical practices of citizen-led health initiatives, and address profound differences in position, privilege and power in research.

1 September 2020 in Social Science & Medicine
Verified
Journal Article
Open access
AFAmelia Fiske
Amelia Fiske
ABAlena Buyx
Alena Buyx
BPBarbara Prainsack
Barbara Prainsack
Increasingly, patients are expected to take initiative and care for themselves through practices of digital self-care: by generating data, by looking for people who can help them make sense of the information, and by being the main actors in disease prevention. Equipped with smart phones and other tools to collect data on various aspects of their bodies and lives from brain waves to activity to diet, patients are expected to prevent lifestyle diseases and diagnose their own medical problems, heralding an entirely new model of care within doctor-patient relationships. In this article we explore physician perspectives on how digital self-care practices are encountered, understood, and incorporated (or not) in the health care system. We carried out in-depth, semi-structured interviews with 15 doctors in Northern Germany in 2018 in order to explore how they included digital data in clinical decisions, how they understood practices of digital self-care, and how they saw these practices affect doctor-patient relationships. Our findings indicate notable frictions between narratives of 'e-patients' and digitally-empowered people in public media and scholarly literature on the one hand, and what doctors reportedly experience in their own practice on the other. We conclude that tech-forward ideas surrounding lay practices of medical emancipation do not 'travel lightly' across different contexts, but are taken up unevenly in and outside of the clinic. Moreover, the personal relationships through which digital self-care practices are undertaken remain central to the meaningful and safe application of new technologies and applications - something that often escapes debates over patient empowerment and digital technology.

2 June 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MGMelanie Goisauf
Melanie Goisauf
MAMónica Cano Abadía
Mónica Cano Abadía
KAKaya Akyüz
Kaya Akyüz
MBMaciej Bobowicz
Maciej Bobowicz
ABAlena Buyx
Alena Buyx
JMJanos Meszaros
Janos Meszaros
Trustworthiness has become a key concept for the ethical development and application of artificial intelligence (AI) in medicine. Various guidelines have formulated key principles, such as fairness, robustness, and explainability, as essential components to achieve trustworthy AI. However, conceptualizations of trustworthy AI often emphasize technical requirements and computational solutions, frequently overlooking broader aspects of fairness and potential biases. These include not only algorithmic bias but also human, institutional, social, and societal factors, which are critical to foster AI systems that are both ethically sound and socially responsible. This viewpoint article presents an interdisciplinary approach to analyzing trust in AI and trustworthy AI within the medical context, focusing on (1) social sciences and humanities conceptualizations and legal perspectives on trust and (2) their implications for trustworthy AI in health care. It focuses on real-world challenges in medicine that are often underrepresented in theoretical discussions to propose a more practice-oriented understanding. Insights were gathered from an interdisciplinary workshop with experts from various disciplines involved in the development and application of medical AI, particularly in oncological imaging and genomics, complemented by theoretical approaches related to trust in AI. Results emphasize that, beyond common issues of bias and fairness, knowledge and human involvement are essential for trustworthy AI. Stakeholder engagement throughout the AI life cycle emerged as crucial, supporting a human- and multicentered framework for trustworthy AI implementation. Findings emphasize that trust in medical AI depends on providing meaningful, user-oriented information and balancing knowledge with acceptable uncertainty. Experts highlighted the importance of confidence in the tool's functionality, specifically that it performs as expected. Trustworthiness was shown to be not a feature but rather a relational process, involving humans, their expertise, and the broader social or institutional contexts in which AI tools operate. Trust is dynamic, shaped by interactions among individuals, technologies, and institutions, and ultimately centers on people rather than tools alone. Tools are evaluated based on reliability and credibility, yet trust fundamentally relies on human connections. The article underscores the development of AI tools that are not only technically sound but also ethically robust and broadly accepted by end users, contributing to more effective and equitable AI-mediated health care. Findings highlight that building AI trustworthiness in health care requires a human-centered, multistakeholder approach with diverse and inclusive engagement. To promote equity, we recommend that AI development teams involve all relevant stakeholders at every stage of the AI lifecycle—from conception, technical development, clinical validation, and real-world deployment.